Combination of 68Ga-FAPI-04 and Dedicated Breast PET (MAMMI PET) Outperformed Breast MRI and 18F-FDG PET/CT by Revealing Nipple and Skin Involvement of Breast Cancer

被引:0
|
作者
Simsek, Duygu Has [1 ]
Oflas, Melis [1 ]
Yilmaz, Ravza [2 ]
Tukenmez, Mustafa [3 ]
Kuyumcu, Serkan [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Nucl Med, Turgut Ozal Millet St, TR-34093 Istanbul, Turkiye
[2] Istanbul Univ, Istanbul Fac Med, Dept Radiol, Istanbul, Turkiye
[3] Istanbul Univ, Istanbul Fac Med, Dept Gen Surg, Istanbul, Turkiye
关键词
F-18-FDG PET/CT; Ga-68-FAPI; breast cancer; dbPET; MAMMI PET;
D O I
10.1097/RLU.0000000000005088
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 41-year-old woman with newly diagnosed breast cancer had suspicious clinical findings of skin involvement on physical examination. The primary tumor had no FDG uptake in F-18-FDG PET/CT. Nipple and skin had no pathologic enhancement for invasion in breast MRI. Because the T stage was unclear, the patient underwent( 68)Ga-FAPI-04 PET/CT for further evaluation. Combination of Ga-68-FAPI-04 with dedicated breast PET (MAMMI PET) showed nipple and skin involvement of breast cancer with intense FAPI uptake. Consequently, a skin-sparing mastectomy was performed. Histopathological examination confirmed invasive lobular carcinoma infiltration of the deep dermis in the nipple and skin tissue.
引用
收藏
页码:e290 / e291
页数:2
相关论文
共 50 条
  • [21] Comparison of the diagnostic efficacy of 68Ga-FAPI-04 PET/MR and 18F-FDG PET/CT in patients with pancreatic cancer
    Zhang, Zeyu
    Jia, Guorong
    Pan, Guixia
    Cao, Kai
    Yang, Qinqin
    Meng, Hongyu
    Yang, Jian
    Zhang, Lu
    Wang, Tao
    Cheng, Chao
    Zuo, Changjing
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (08) : 2877 - 2888
  • [22] Primary Extraosseous Ewing Sarcoma on 18F-FDG and 68Ga-FAPI-04 PET/CT
    Tao, Yi
    Wang, Feifei
    Yan, Jiao
    Chen, Zhengguo
    Wu, Chunyan
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (03) : 263 - 264
  • [23] 68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
    Wang, Hao
    Zhu, Wenwei
    Ren, Shuhua
    Kong, Yanyan
    Huang, Qi
    Zhao, Jun
    Guan, Yihui
    Jia, Huliang
    Chen, Jinhong
    Lu, Lu
    Xie, Fang
    Qin, Lunxiu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Primary Breast Lymphoma Detected by 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT
    Tao, Yi
    Wang, Feifei
    Chen, Liming
    Huang, Zhanwen
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (04) : 339 - 341
  • [25] 68Ga-FAPI-04 PET/CT Versus 18F-FDG PET/CT in the Detection of Malignant Gastrointestinal Stromal Tumor
    Zhang, Zeyu
    Jiang, Hongyuan
    Zhang, Lu
    Cheng, Chao
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : 61 - 63
  • [26] 18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer
    Kiran, Murat Yilmaz
    Has Simsek, Duygu
    Sanli, Yasemin
    Kuyumcu, Serkan
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (02) : E87 - E88
  • [27] Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer
    Can, Canan
    Kepenek, Ferat
    Komek, Halil
    Gundogan, Cihan
    Kaplan, Ihsan
    Tasdemir, Bekir
    Guzel, Yunus
    Aguloglu, Nursin
    Karaoglan, Huseyin
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (10) : 1084 - 1091
  • [28] Comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for the Diagnosis of Lesions in Patients with Colorectal Cancer
    Lin, X.
    Zhu, H.
    Zhao, W.
    Zhang, Y.
    Wu, A.
    Yang, Z.
    Wang, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S30 - S30
  • [29] Comparison of 68Ga-FAPI-04 PET/CT, CECT and 18F-FDG PET/CT in the evaluation of peritoneal metastases from gastrointestinal cancer
    Zhou, Yushan
    Cheng, Junjun
    Su, Minggang
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [30] The Added Value of Contrast-Enhanced 68Ga-FAPI-04 PET/MRI Over 18F-FDG PET/CT in Hepatocellular Carcinoma
    Ding, Jie
    Zhao, Jun
    Chen, Xing
    You, Zhiwen
    Wang, Haiyan
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (11) : 1039 - 1040